Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Globus Medical Inc (GMED)

Globus Medical Inc (GMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,842,115
  • Shares Outstanding, K 97,781
  • Annual Sales, $ 785,370 K
  • Annual Income, $ 155,210 K
  • 60-Month Beta 0.98
  • Price/Sales 6.09
  • Price/Cash Flow 21.90
  • Price/Book 3.58
Trade GMED with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.30
  • Number of Estimates 7
  • High Estimate 0.35
  • Low Estimate 0.20
  • Prior Year 0.43
  • Growth Rate Est. (year over year) -30.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.28 +2.15%
on 09/24/20
57.69 -14.51%
on 09/02/20
-7.52 (-13.23%)
since 09/01/20
3-Month
44.61 +10.56%
on 07/09/20
58.23 -15.30%
on 08/06/20
+0.65 (+1.34%)
since 07/01/20
52-Week
33.41 +47.62%
on 03/16/20
60.15 -18.00%
on 12/20/19
-0.96 (-1.91%)
since 10/01/19

Most Recent Stories

More News
LabCorp Coronavirus Test Sales Aid Growth Amid Volume Woes

There has been a steady recovery in the Base Business of LabCorp (LH).

QGEN : 53.17 (+1.74%)
LH : 188.40 (+0.07%)
TMO : 441.75 (+0.05%)
GMED : 49.47 (-0.10%)
Thermo Fisher Rides on End Market Growth, Test Revenues

Thermo Fisher's (TMO) pharma and biotech end markets register growth on robust performance in bioproduction and pharma services businesses.

SRDX : 38.56 (-0.90%)
QGEN : 53.17 (+1.74%)
TMO : 441.75 (+0.05%)
GMED : 49.47 (-0.10%)
Here's Why You Should Hold on to Hologic (HOLX) Stock for Now

Investors continue to be optimistic about Hologic (HOLX) on robust growth of the Diagnostics segment and regulatory approvals.

HOLX : 66.56 (+0.14%)
QGEN : 53.17 (+1.74%)
TMO : 441.75 (+0.05%)
GMED : 49.47 (-0.10%)
Hologic (HOLX) Receives EUA for Asymptomatic Coronavirus Testing

The FDA approves Hologic's (HOLX) Panther Fusion SARS-CoV-2 assay and pooling protocol to curb the unrelenting spread of coronavirus.

HOLX : 66.56 (+0.14%)
QGEN : 53.17 (+1.74%)
TMO : 441.75 (+0.05%)
GMED : 49.47 (-0.10%)
AngioDynamics (ANGO) in Focus: Stock Moves 6.2% Higher

AngioDynamics (ANGO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

ANGO : 11.70 (-2.99%)
GMED : 49.47 (-0.10%)
QIAGEN (QGEN) Completes Buyout of NeuMoDx, Expands Portfolio

QIAGEN (QGEN) expands portfolio of automated testing solutions to address laboratory needs in almost any setting for molecular diagnostics via the completed buyout of NeuMoDx.

HOLX : 66.56 (+0.14%)
QGEN : 53.17 (+1.74%)
TMO : 441.75 (+0.05%)
GMED : 49.47 (-0.10%)
The Zacks Analyst Blog Highlights: Teradyne, ABB, Brooks Automation and Globus Medical

The Zacks Analyst Blog Highlights: Teradyne, ABB, Brooks Automation and Globus Medical

ABB : 25.77 (+1.26%)
BRKS : 47.83 (+3.39%)
TER : 81.20 (+2.19%)
GMED : 49.47 (-0.10%)
4 Robotics Stocks to Skyrocket on Technological Advancement

Robotics stocks offer great opportunities for growth investors and recent adoptions have accelerated the industry's growth rapidly.

ABB : 25.77 (+1.26%)
BRKS : 47.83 (+3.39%)
TER : 81.20 (+2.19%)
GMED : 49.47 (-0.10%)
QIAGEN, Ellume Extend Alliance for COVID-19 Antigen Test

QIAGEN (QGEN) extends partnership with Ellume to offer the second COVID-19 test utilizing the latter's technology and strengthening its own COVID-19-testing portfolio.

HOLX : 66.56 (+0.14%)
QGEN : 53.17 (+1.74%)
TMO : 441.75 (+0.05%)
GMED : 49.47 (-0.10%)
Abbott Banks on EPD, Nutrition Growth to Beat Coronavirus Woes

Abbott (ABT) expects to register strong growth for the second half of 2020 within established pharmaceuticals (EPD).

HOLX : 66.56 (+0.14%)
ABT : 109.64 (+0.74%)
TMO : 441.75 (+0.05%)
GMED : 49.47 (-0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products...

See More

Key Turning Points

2nd Resistance Point 51.16
1st Resistance Point 50.34
Last Price 49.47
1st Support Level 48.76
2nd Support Level 48.00

See More

52-Week High 60.15
Fibonacci 61.8% 49.94
Last Price 49.47
Fibonacci 50% 46.78
Fibonacci 38.2% 43.62
52-Week Low 33.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar